Helmy Eltoukhy, Co-Chief Executive Officer at Guardant Health, Inc. (GH), bought 184,000 shares at $97.90 ($17.7M) on 2021-11-19, disclosed to the SEC on 2021-11-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $97.90 | 37,591 | $3.7M | 20.8% |
| 2 | $97.90 | 37,591 | $3.7M | 20.8% |
| 3 | $98.75 | 12,409 | $1.2M | 6.9% |
| 4 | $98.75 | 12,409 | $1.2M | 6.9% |
| 5 | $92.23 | 3,106 | $286K | 1.6% |
| 6 | $92.23 | 3,106 |
| $286K |
| 1.6% |
| 7 | $93.04 | 26,394 | $2.5M | 13.9% |
| 8 | $93.04 | 26,394 | $2.5M | 13.9% |
| 9 | $94.00 | 5,000 | $470K | 2.7% |
| 10 | $95.50 | 5,000 | $478K | 2.7% |
| 11 | $96.83 | 14,900 | $1.4M | 8.2% |
| 12 | $98.00 | 100 | $10K | 0.1% |
| Total | $96.17 avg | 184,000 | $17.7M | 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | SELL | 2021-04-26 | $2.6M | — | Filing → |